Menu
Currency
GWAS Study

Genome-wide association study of blood pressure and hypertension.

Levy D, Ehret GB, Rice K et al.

19430479 PubMed ID
GWAS Study Type
63569 Participants
147 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LD
Levy D
EG
Ehret GB
RK
Rice K
VG
Verwoert GC
LL
Launer LJ
DA
Dehghan A
GN
Glazer NL
MA
Morrison AC
JA
Johnson AD
AT
Aspelund T
AY
Aulchenko Y
LT
Lumley T
KA
Köttgen A
VR
Vasan RS
RF
Rivadeneira F
EG
Eiriksdottir G
GX
Guo X
AD
Arking DE
MG
Mitchell GF
MF
Mattace-Raso FU
SA
Smith AV
TK
Taylor K
SR
Scharpf RB
HS
Hwang SJ
SE
Sijbrands EJ
BJ
Bis J
HT
Harris TB
GS
Ganesh SK
OC
O'Donnell CJ
HA
Hofman A
RJ
Rotter JI
CJ
Coresh J
BE
Benjamin EJ
UA
Uitterlinden AG
HG
Heiss G
FC
Fox CS
WJ
Witteman JC
BE
Boerwinkle E
WT
Wang TJ
GV
Gudnason V
LM
Larson MG
CA
Chakravarti A
PB
Psaty BM
VD
van Duijn CM
Chapter II

Abstract

Summary of the research findings

Blood pressure is a major cardiovascular disease risk factor. To date, few variants associated with interindividual blood pressure variation have been identified and replicated. Here we report results of a genome-wide association study of systolic (SBP) and diastolic (DBP) blood pressure and hypertension in the CHARGE Consortium (n = 29,136), identifying 13 SNPs for SBP, 20 for DBP and 10 for hypertension at P < 4 × 10(-7). The top ten loci for SBP and DBP were incorporated into a risk score; mean BP and prevalence of hypertension increased in relation to the number of risk alleles carried. When ten CHARGE SNPs for each trait were included in a joint meta-analysis with the Global BPgen Consortium (n = 34,433), four CHARGE loci attained genome-wide significance (P < 5 × 10(-8)) for SBP (ATP2B1, CYP17A1, PLEKHA7, SH2B3), six for DBP (ATP2B1, CACNB2, CSK-ULK3, SH2B3, TBX3-TBX5, ULK4) and one for hypertension (ATP2B1). Identifying genes associated with blood pressure advances our understanding of blood pressure regulation and highlights potential drug targets for the prevention or treatment of hypertension.

29,136 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

63569
Total Participants
GWAS
Study Type
Yes
Replicated
34,433 European ancestry individuals
Replication Participants
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.